Conditioning regimens with or without antibody (Ab:ATG or alemtuzumab)
Drug Combination . | No Ab . | ATG . | Alemtuzumab . | Total . |
|---|---|---|---|---|
| FD + TBI | 34 | 0 | 1 | 35 |
| FD + busulfan | 5 | 30 | 2 | 37 |
| FD + busulfan + other | 0 | 6 | 1 | 7 |
| FD + melphalan | 34 | 7 | 44 | 85 |
| FD + melphalan + TBI | 4 | 0 | 1 | 5 |
| FD + melphalan + cyclo | 2 | 13 | 4 | 19 |
| FD + cyclo | 12 | 3 | 1 | 16 |
| FD + cyclo + TBI | 0 | 11 | 0 | 11 |
| Other | 4 | 9 | 1 | 13 |
Drug Combination . | No Ab . | ATG . | Alemtuzumab . | Total . |
|---|---|---|---|---|
| FD + TBI | 34 | 0 | 1 | 35 |
| FD + busulfan | 5 | 30 | 2 | 37 |
| FD + busulfan + other | 0 | 6 | 1 | 7 |
| FD + melphalan | 34 | 7 | 44 | 85 |
| FD + melphalan + TBI | 4 | 0 | 1 | 5 |
| FD + melphalan + cyclo | 2 | 13 | 4 | 19 |
| FD + cyclo | 12 | 3 | 1 | 16 |
| FD + cyclo + TBI | 0 | 11 | 0 | 11 |
| Other | 4 | 9 | 1 | 13 |
FD indicates fludarabine; Cyclo, cyclophosphamide; TBI, total body irradiation.